510(k) device
Omnipod 5 ACE Pump
Insulet Corporation · Alternate Controller Enabled Insulin Infusion Pump (QFG, Class II) · First FDA decision Jan 27, 2022, newest Oct 18, 2023Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
Breakthrough-designated
Device trials
0
Naming "Omnipod 5 ACE"
MAUDE reports
0
Brand "Omnipod 5 ACE", since 2015
PubMed studies
0
Mentioning "Omnipod 5 ACE"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Omnipod 5 ACE Pump
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Omnipod 5 ACE Pump510(k)
K231826 · Decided Oct 18, 2023 · 119 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
- Omnipod 5 ACE Pump (Pod)Breakthrough510(k)
K203768 · Decided Jan 27, 2022 · 400 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Insulin Infusion PumpNational analysisReview closedCAG-00041NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Omnipod 5 ACE", any status and sponsor, newest update first.
No registered device study names "Omnipod 5 ACE".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Omnipod 5 ACE", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QFG
1,370,384 reports: 1,216,047 malfunction, 153,806 injury, 383 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2603-2026 · Started May 20, 2026 · Posted by FDA Jun 30, 2026
Reason given: External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may...
Cause as FDA categorized it: Process design · Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG)
Z-1797-2026 · Started Mar 12, 2026 · Posted by FDA Apr 10, 2026
Reason given: Due to a manufacturing defect, certain Omnipod 5 Pods from 49 lots have an internal soft cannula tear that results in insulin leaking into the Pod instead of being delivered to the user regardless of basal or bolus delivery. This defect results from damage to the unexposed portion of the soft cannula during...
Cause as FDA categorized it: Process design · Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG)
Z-0132-2026 · Started Sep 11, 2025 · Posted by FDA Oct 10, 2025
Reason given: The failure occurs if a user on the Omnipod 5 iOS application selects and holds down on a manual entry field, to magnify the visual field using the magnifying feature of the iPhone, while simultaneously selecting a single number on the keyboard. This causes the single digit number to duplicate. This could result in...
Cause as FDA categorized it: Software design · Device type: Continuous Glucose Monitor Informed Insulin Dose Calculator (QRX)
4 more recall records with a free account
Published research
The most relevant PubMed records for "Omnipod 5 ACE"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QFG.
- Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. · 510(k) 2025
- t:slim X2 insulin pump with interoperable technologyTandem Diabetes Care, Inc. · De Novo 2025
- iLet ACE PumpBeta Bionics, Inc. · 510(k) 2026
- DEKA ACE Pump SystemDeka Research and Development · 510(k) 2024
- Mint ACE PumpBeta Bionics, Inc. · 510(k) 2026
- MiniMed 780G Insulin Pump (MMT-1884)Medtronic Minimed, Inc. · 510(k) 2026
- twiist Automated Insulin Delivery (AID) SystemDeka Research and Development · 510(k) 2026
- MiniMed Flex pumpMedtronic Minimed, Inc. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.